SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2017

Liquid Biopsies and Minimally-Invasive Diagnostics 2017
Date: October 5 - 6, 2017
Venue: Coronado Island Marriott Resort & Spa, Coronado Island, California USA

Keynote Speakers

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, University Medical Center Utrecht, The Netherlands

John Sninsky

John Sninsky
Chief Scientific Officer, CareDx

Hsian-Rong Tseng

Hsian-Rong Tseng
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles

Allison Ballmer

Allison Ballmer
International Business Leader, Roche Molecular Systems, Inc.

Yoon-Kyoung Cho

Yoon-Kyoung Cho
Professor, Ulsan National Institute of Science & Technology; Group leader, IBS

Chamindie Punyadeera

Chamindie Punyadeera
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas

AmirAli Talasaz

AmirAli Talasaz
Co-Founder, President & COO, Guardant Health

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Paul Song

Paul Song
Chief Medical Officer, Cynvenio Biosystems

Fred Kramer

Fred Kramer
Professor, New Jersey Medical School Rutgers University

Michael Heller

Michael Heller
Professor, University of California San Diego

Shana Kelley

Shana Kelley
Professor, University Of Toronto

Ellen Beasley

Ellen Beasley
Senior Vice President, Genomic Health Inc

Walter Koch

Walter Koch
Vice President, Roche Molecular Systems

Utkan Demirci

Utkan Demirci
Associate Professor, Stanford University School of Medicine

Nazneen Aziz

Nazneen Aziz
Executive Director, Kaiser Permanente Research Bank

Overview

Select Biosciences, Inc. Fourth Annual Liquid Biopsies and Minimally-Invasive Diagnostics 2017 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

This Liquid Biopsies Conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring.

This conference is held concurrently with the NGS, RNA-Seq, Single Cell Analysis & Single Molecule Analysis: Research to Diagnostics 2017 Conference enabling delegates full access to the presentations, co-located exhibit hall and extensive networking opportunities.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 25 September 2017

Agenda Topics

  • Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
  • Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
    • Emerging Technologies and Emerging Companies Showcase
    • Technology Platforms for Interrogation
  • Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
  • Extracellular Vesicles (EVs) and Exosomes: Potential for Development of Liquid Biopsies
  • US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies

Confirmed Speakers to date

Partha Das, Global Medical Affairs Lead, Genomics and Oncology, Roche Molecular Systems
Robert Kinders, Sr. Principal Scientist and Head, Laboratory of Human Toxicology and Pharmacology, Frederick National Laboratory for Cancer Research
Anders Nygren, Senior Director, Research and Development, Agena Biosciences
Balaji Panchapakesan, Associate Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)
Ian Papautsky, Professor, Department of Bioengineering, University of Illinois at Chicago
Shivani Sharma, Associate Director, California NanoSystems Institute, California NanoSystems Institute, UCLA
Kai Wang, Principle Scientist, Institute for Systems Biology
William Whitford, Strategic Solutions Leader, GE Healthcare
Dale Yuzuki, Director of Market Development, Oncology, SeraCare Life Sciences, Inc.


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Corporate Sponsors
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean